Contracts › 75N95021F00001
75N95021F00001: Characterization of a Non-Paralyzing Bont-Based Biopharmaceutical for the Treatment of Neuropathic Pain
Awarded to Lovelace Biomedical Research Institute by National Institutes of Health (NIH).
$1.6Mobligated
$2.0Mpotential value
30 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N95021F00001 |
|---|---|
| Vehicle | 75N95019D00012 |
| Awardee | Lovelace Biomedical Research Institute |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | NM |
| Period of performance | 24 September 2021 to 30 June 2027 |
| Potential end | 30 June 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record